🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to welcome folks to the new motif neurotech office, manufacturing, and R&D space at the TMC innovation building in Houston! The team is already hard at work building next-gen therapeutic BCIs... and eating cookies.

motifneuro.tech

Come see the cool stuff the team is up to! BCI is becoming an industry that can address so many disorders:👇

Come see Emily Chang discuss the future of BCI with motif neurotech, Synchron, and others. Spoilers: a certain Nobel Laureate and “god father of AI” comes out as a potential BCI adopter, and our very own Jon Nelson makes someone cry.. (as usual!)

Heading to the icon’s last show tomorrow in Vancouver and feeling E22. IYKYK 🫶 #ErasTourVancouver

Can you think of a more controversial Christmas dinner topic than "What is a BCI?" Today in @NatBME, we propose an application-based taxonomy -> Clearer language for patients, regulators, and innovators alike. Proud to collaborate with Jacob Robinson and an incredible team! 🎁

Intriguing read by Jacob Robinson and Sumner L Norman. While broadening the definition of BCI may be controversial, it encourages developers to expand their perspective and learn from existing technologies. nature.com/articles/s4155…

My rationale for our controversial comment in Nature BME proposing an application-based taxonomy for BCI (unrolled from LinkedIn): Why we should consider labeling BCI based on its intended use. substack.com/inbox/post/154…

Just out Nature Reviews Bioengineering, check out our perspective on integrating bioelectronics with cell-based synthetic biology. Shout out to this awesome crew: Omid Veiseh, Tzahi Cohen-Karni, @DrRituRaman, Katie Galloway, Jacob Robinson, and Christian Schreib nature.com/articles/s4422… 🧵1/7

🚨I’m super excited to announce the teams we’re funding as part of our Precision Neurotechnologies programme.🚨 They’ll work on the next-gen tech that’ll allow us to understand + treat a wider range of brain disorders than ever before. Read more below (1/3)

We've been selected by ARIA to develop a network of neural devices designed to monitor and regulate mental and cognitive states without brain surgery. The UK-based program led by Jacques Carolan is contributing £69M to unlock the full potential of #neurotech.

We're honored to be selected by ARIA for a multimillion-dollar award through their Precision Neurotechnologies Program. This funding will accelerate the development of our therapeutic Brain-Computer Interface to treat mood, attention, and sleep disorders 🧠🚀

We're thrilled to formally welcome Joshua Woods, PhD as our Senior Electrical Engineer! Josh has been integral in our world for some time now. His doctoral work at Jacob Robinson Rice University included pioneering the first DOT and magnetoelectric power for neural networks.

Just a reminder that the abstract submission deadline for InterfaceNeuro is coming up on March 14. Submit your work and come join us for this interdisciplinary meeting!

Biotech Launch Pad Fellows: A winning formula | Giving | ⁦Rice University⁩ ⁦Biotech Launch Pad⁩ giving.rice.edu/biotech-launch…

Totally blown away by the experience of presenting at MARS: Fascinating dinners with Jeff Bezos, Ron Howard, wonderful founders, scientists, and folks from Amazon. I even got to fan-boy over my favorite podcasters Ben Gilbert and David Rosenthal (who were super kind BTW). Most